504
Participants
Start Date
May 14, 2019
Primary Completion Date
March 20, 2022
Study Completion Date
July 27, 2022
Tripterygium Wilfordii
Oral Tripterygium Wilfordii 20mg thrice daily for 24 weeks.
Methotrexate
Oral methotrexate 7.5-15mg per week for 24 weeks. The starting dose was 7.5mg per week, then increased to 15mg (max 0.3mg/Kg) per week in 4 weeks. Folic acid at the dose of 5 mg per week were applied to all participants.
Yisaipu
Yisaipu, a Tumor Necrosis Factor Receptor Fusion Protein, was subcutaneously injected at a dose of 50 mg once a week for 24 weeks.
Deptment of Rheumatology, Peking Union Medical College Hospital, Beijing
Peking Union Medical College Hospital
OTHER